Publications
Detailed Information
Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, S. H. | - |
dc.contributor.author | Yoo, K. H. | - |
dc.contributor.author | Sung, K. W. | - |
dc.contributor.author | Koo, H. H. | - |
dc.contributor.author | Kwon, M. M. | - |
dc.contributor.author | Park, B-K | - |
dc.contributor.author | Park, J. A. | - |
dc.contributor.author | Seo, J. J. | - |
dc.contributor.author | Shin, H. Y. | - |
dc.contributor.author | Ahn, H. S. | - |
dc.contributor.author | Kang, H. J. | - |
dc.contributor.author | Im, H. J. | - |
dc.contributor.author | Kim, Y. Y. | - |
dc.contributor.author | Park, H. J. | - |
dc.contributor.author | Kwon, Y. J. | - |
dc.date.accessioned | 2012-06-12T04:53:21Z | - |
dc.date.available | 2012-06-12T04:53:21Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.citation | BONE MARROW TRANSPLANTATION; Vol.45 8; 1287-1293 | ko_KR |
dc.identifier.issn | 0268-3369 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77001 | - |
dc.description.abstract | Four hundred and sixty-seven hematopoietic stem cell transplantations (HSCTs) (217 autologous and 250 allogeneic HSCT) were performed in 374 children at four pediatric HSCT centers in Korea from January 2005 to December 2007. Among 467 transplants, veno-occlusive disease (VOD) developed in 72 transplants (15.4%) at a median of 10 days after HSCT. Multivariate analysis showed that BU or TBI-containing regimen (P = 0.002), VOD prophylaxis without lipo-prostaglandin E1 (PGE1) (P = 0.012), number of previous HSCT (P = 0.014), and pretransplant serum ferritin (P = 0.018) were independent risk factors for developing VOD. Mean serum ferritin levels were significantly higher in HSCT with VOD (2109.6 +/- 2842.5 ng/ml) than in HSCT without VOD (1315.9 +/- 1094.4 ng/ml) (P < 0.001). The relative risk of death within 100 days of HSCT in transplants with VOD compared with transplants without VOD was 3.39 (confidence interval: 1.78-6.45). Our results suggest that lipo-PGE1 might have a protective effect against the development of VOD, and pretransplant serum ferritin could act as a risk factor for VOD. A larger prospective study is needed to confirm a possible role of lipo-PGE1 and iron chelation therapy in reducing the incidence of VOD. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | NATURE PUBLISHING GROUP | ko_KR |
dc.subject | veno-occlusive disease | ko_KR |
dc.subject | lipid microspheres-containing prostaglandin E1 | ko_KR |
dc.subject | ferritin | ko_KR |
dc.subject | prophylaxis | ko_KR |
dc.subject | hematopoietic stem cell transplantation | ko_KR |
dc.title | Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1038/bmt.2009.349 | - |
dc.citation.journaltitle | BONE MARROW TRANSPLANTATION | - |
dc.description.citedreference | Cutting R, 2008, BRIT J HAEMATOL, V143, P748, DOI 10.1111/j.1365-2141.2008.07399.x | - |
dc.description.citedreference | Cacchione A, 2008, BONE MARROW TRANSPL, V42, P449, DOI 10.1038/bmt.2008.186 | - |
dc.description.citedreference | Qureshi A, 2008, PEDIATR BLOOD CANCER, V50, P831, DOI 10.1002/pbc.21425 | - |
dc.description.citedreference | Jastaniah W, 2008, PEDIATR BLOOD CANCER, V50, P319, DOI 10.1002/pbe.21260 | - |
dc.description.citedreference | Dignan F, 2007, BONE MARROW TRANSPL, V40, P79, DOI 10.1038/sj.bmt.1705696 | - |
dc.description.citedreference | Armand P, 2007, BLOOD, V109, P4586, DOI 10.1182/blood-2006-10-054924 | - |
dc.description.citedreference | Corbacioglu S, 2006, BONE MARROW TRANSPL, V38, P547, DOI 10.1038/sj.bmt.1705485 | - |
dc.description.citedreference | Song JS, 2006, J KOREAN MED SCI, V21, P897 | - |
dc.description.citedreference | Cesaro S, 2005, HAEMATOL-HEMATOL J, V90, P1396 | - |
dc.description.citedreference | Beelen DW, 2005, BONE MARROW TRANSPL, V35, P233, DOI 10.1038/sj.bmt.1704784 | - |
dc.description.citedreference | Evens AM, 2004, BONE MARROW TRANSPL, V34, P561, DOI 10.1038/sj.bmt.1704591 | - |
dc.description.citedreference | Chalandon Y, 2004, BIOL BLOOD MARROW TR, V10, P347, DOI 10.1016/j.bbmt.2004.01.002 | - |
dc.description.citedreference | Wadleigh M, 2003, BLOOD, V102, P1578, DOI 10.1182/blood-2003-01-0255 | - |
dc.description.citedreference | Barker CC, 2003, BONE MARROW TRANSPL, V32, P79, DOI 10.1038/sj.bmt.1704069 | - |
dc.description.citedreference | Forrest DL, 2003, BONE MARROW TRANSPL, V31, P1143, DOI 10.1038/sj.bmt.1704087 | - |
dc.description.citedreference | Simon M, 2001, BONE MARROW TRANSPL, V27, P627 | - |
dc.description.citedreference | Valteau-Couanet D, 2000, BONE MARROW TRANSPL, V25, P937 | - |
dc.description.citedreference | Girinsky T, 2000, J CLIN ONCOL, V18, P981 | - |
dc.description.citedreference | MORADO M, 2000, HEMATOLOGY, V4, P505 | - |
dc.description.citedreference | Toh HC, 1999, BONE MARROW TRANSPL, V24, P891 | - |
dc.description.citedreference | Hasegawa S, 1998, BONE MARROW TRANSPL, V22, P1191 | - |
dc.description.citedreference | Carreras E, 1998, BLOOD, V92, P3599 | - |
dc.description.citedreference | Olivieri NF, 1998, NEW ENGL J MED, V339, P417 | - |
dc.description.citedreference | Styler MJ, 1996, BONE MARROW TRANSPL, V18, P171 | - |
dc.description.citedreference | OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574 | - |
dc.description.citedreference | BEARMAN SI, 1993, J CLIN ONCOL, V11, P1729 | - |
dc.description.citedreference | BEARMAN SI, 1993, BRIT J HAEMATOL, V84, P724 | - |
dc.description.citedreference | MCDONALD GB, 1993, ANN INTERN MED, V118, P255 | - |
dc.description.citedreference | RADICH JP, 1993, J CLIN ONCOL, V11, P304 | - |
dc.description.citedreference | SHULMAN HM, 1992, BONE MARROW TRANSPL, V10, P197 | - |
dc.description.citedreference | MERESSE V, 1992, BONE MARROW TRANSPL, V10, P135 | - |
dc.description.citedreference | ATTAL M, 1992, BLOOD, V79, P2834 | - |
dc.description.citedreference | MARSAVILA L, 1991, EUR J HAEMATOL, V47, P346 | - |
dc.description.citedreference | OZKAYNAK MF, 1991, BONE MARROW TRANSPL, V7, P467 | - |
dc.description.citedreference | MIZUSHIMA Y, 1990, PROSTAG LEUKOTR ESS, V41, P269 | - |
dc.description.citedreference | BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P407 | - |
dc.description.citedreference | GLUCKMAN E, 1990, BRIT J HAEMATOL, V74, P277 | - |
dc.description.citedreference | COSSET JM, 1989, RADIOTHER ONCOL, V15, P151 | - |
dc.description.citedreference | GROCHOW LB, 1989, CANCER CHEMOTH PHARM, V25, P55 | - |
dc.description.citedreference | BRUGIERES L, 1988, BONE MARROW TRANSPL, V3, P53 | - |
dc.description.citedreference | SIM AK, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1206 | - |
dc.description.citedreference | OTOMO S, 1985, DRUG EXP CLIN RES, V11, P627 | - |
dc.description.citedreference | MIZUSHIMA Y, 1983, J PHARM PHARMACOL, V35, P666 | - |
dc.description.citedreference | PIPER PJ, 1970, NATURE, V225, P600 | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.